Tag: Glenmark USA
GENERAL Glenmark Scales Up US Injectables Presence With Generic Sugammadex

Glenmark Pharmaceuticals Inc., USA, has launched Sugammadex Injection in the United States, expanding its injectables portfolio with a generic version of Merck Sharp & Dohme LLC’s blockbuster anaesthesia reversal drug BRIDION. The company said the product is available in 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) single-dose vials. Glenmark’s Sugammadex Injection […]

CW Bureau · Jul 29, 2026
GENERAL Glenmark Pharma Launches Generic Vancomycin Injection In US Market

Glenmark Pharmaceuticals has announced the launch of Vancomycin Hydrochloride for Injection USP in the U.S. market, expanding its injectable portfolio amid growing demand for affordable hospital medicines. The company said the product will be available in 500 mg/vial and 1 g/vial strengths through its U.S.-based arm, Glenmark Pharmaceuticals Inc., USA. Targets $37.9 million market opportunity […]

CW Bureau · May 18, 2026